Go back

Pharmaceutical exports drop despite R&D funding rise

UK exports of pharmaceutical products have fallen by 8 per cent in four years despite a rise in government spending on R&D, data compiled by the government’s Office for Life Sciences has shown.

The UK’s pharmaceutical exports had a value of $33.3 billion (£24.7bn) in 2016, down from a peak of $36.4bn in 2012, despite a “steady rise” in export values up to that point from $29.1bn in 2007. The fall occured despite an overall increase in government and charity spending on medical R&D, according to a report published by the office on 16 May.

Overall non-industry spending on R&D by three big funders stood at £3.6bn in 2016, according to the report. The largest proportion—45 per cent, or £1.4bn—came from members of the Association of Medical Research Charities, with the remainder split almost evenly between the Medical Research Council and the National Institute for Health Research.

This article on Research Professional News is only available to Research Professional or Pivot-RP users.

Research Professional users can log in and view the article via this link

Pivot-RP users can log in and view the article via this link.